Author

Jeffrey J. W. Verschuren

Observed names: J. J. W. Verschuren, J.J.W. Verschuren, Jeffrey J W Verschuren, Jeffrey J.W. Verschuren, Jeffrey JW Verschuren, Jeffrey Johan Willem Verschuren, Verschuren, J.J.W.

Observed institutions: Leiden University, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Medical University of Graz, Charles University, Leiden University Medical Center, Institute of Cardiology, University College London

OpenAlex ID: A5110161145

Restenosis after PCI. Part 1: pathophysiology and risk factors

2011 · J. Wouter Jukema, Jeffrey J. W. Verschuren, et al. · Nature Reviews Cardiology · 301

Secretory Phospholipase A2-IIA and Cardiovascular Disease

2013 · Michael V. Holmes, Tabassome Simon, et al. · Journal of the American College of Cardiology · 125

PDF

Restenosis after PCI. Part 2: prevention and therapy

2011 · J. Wouter Jukema, Tarek A. N. Ahmed, et al. · Nature Reviews Cardiology · 90

A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?

2011 · Jeffrey J.W. Verschuren, Stella Trompet, et al. · European Heart Journal · 71

Pharmacogenetics of Statins: Achievements, Whole-genome Analyses and Future Perspectives

2012 · Iris Postmus, Jeffrey JW Verschuren, et al. · Pharmacogenomics · 45

Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality

2011 · Stella Trompet, Douwe Pons, et al. · Stroke Research and Treatment · 45

PDF

Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction

2012 · Jeffrey J.W. Verschuren, Helèn Boden, et al. · International Journal of Cardiology · 36

Infectious Complications After Simultaneous Pancreas-Kidney Transplantation: A Role for the Lectin Pathway of Complement Activation

2008 · Jeffrey J.W. Verschuren, Anja Roos, et al. · Transplantation · 36

Systematic Testing of Literature Reported Genetic Variation Associated with Coronary Restenosis: Results of the GENDER Study

2012 · Jeffrey J. W. Verschuren, Stella Trompet, et al. · PLoS ONE · 22

PDF

Non-Homologous End-Joining Pathway Associated with Occurrence of Myocardial Infarction: Gene Set Analysis of Genome-Wide Association Study Data

2013 · Jeffrey J. W. Verschuren, Stella Trompet, et al. · PLoS ONE · 20

PDF

Candidate Gene Analysis of Arteriovenous Fistula Failure in Hemodialysis Patients

2013 · Jeffrey J.W. Verschuren, Gurbey Ocak, et al. · Clinical Journal of the American Society of Nephrology · 16

Pathway Analysis Using Genome-Wide Association Study Data for Coronary Restenosis – A Potential Role for the PARVB Gene

2013 · Jeffrey J. W. Verschuren, Stella Trompet, et al. · PLoS ONE · 15

PDF

A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention

2011 · M. Lourdes Sampietro, Stella Trompet, et al. · Human Molecular Genetics · 14

Pharmacogenetics of antiplatelet therapy: ready for clinical application?

2011 · Jeffrey J W Verschuren, J Wouter Jukema · Heart · 9

Candidate Gene Analysis of Mortality in Dialysis Patients

2015 · Tonia C. Rothuizen, Gurbey Ocak, et al. · PLoS ONE · 7

PDF

Genetic determinants of adverse outcome (restenosis, malapposition and thrombosis) after stent implantation

2010 · Sandrin C Bergheanu, Douwe Pons, et al. · Interventional Cardiology · 6

Matrix Metalloproteinases 2 and 3 Gene Polymorphisms and the Risk of Target Vessel Revascularization after Percutaneous Coronary Intervention: Is There Still Room for Determining Genetic Variation of MMPs for Assessment of an Increased Risk of Restenosis?

2010 · J.J.W. Verschuren, M.L. Sampietro, et al. · Disease Markers · 5

Ten-year mortality risk of patients undergoing elective PCI: long-term follow-up of the GENetic Determinants of Restenosis (GENDER) study

2012 · J. J. W. Verschuren, S. Trompet, et al. · Netherlands Heart Journal · 4

PDF

Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction

2012 · Jeffrey J. W. Verschuren, H. Boden, et al. · Data Archiving and Networked Services (DANS) · 3

Poster session 3

2012 · O. Nanka, E. Krejci, et al. · Cardiovascular Research · 3

Matrix metalloproteinases 2 an 3 gene polymorphisms and the risk of target vessel revascularisation after percutaneous coronary intervention

2010 · Jeffrey J. W. Verschuren, M. Lourdes Sampietro, et al. · Data Archiving and Networked Services (DANS) · 2

Annexin A5: genotypic risk marker for clinical restenosis after percutaneous coronary intervention

2010 · M.M. Ewing, Jeffrey J. W. Verschuren, et al. · Data Archiving and Networked Services (DANS) · 1

Genetic and pharmacogenetic determinants of cardiovascular disease

2013 · Jeffrey Johan Willem Verschuren · Leiden Repository (Leiden University)

PDF

Abstract 12855: Added Value of Pharmacogenetic Factors to a Clinical Risk Score for Prediction f oThrombotic Events After ST-Segment Elevation Myocardial Infarction

2012 · Jeffrey J. W. Verschuren, Helèn Boden, et al. · Circulation

Variation in DNA repair genes and risk of cardiovascular events

2012 · Jeffrey J. W. Verschuren, Judith A.M. Wessels, et al. · Data Archiving and Networked Services (DANS)

Works count: 37

Citation count: 876

H-index: 13

I10-index: 13